{"id":"https://openalex.org/W2265091238","doi":"https://doi.org/10.1038/leu.2015.265","title":"Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes","display_name":"Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes","publication_year":2015,"publication_date":"2015-10-07","ids":{"openalex":"https://openalex.org/W2265091238","doi":"https://doi.org/10.1038/leu.2015.265","mag":"2265091238","pmid":"https://pubmed.ncbi.nlm.nih.gov/26442612","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4832070"},"language":"en","primary_location":{"id":"doi:10.1038/leu.2015.265","doi":"https://doi.org/10.1038/leu.2015.265","is_oa":true,"landing_page_url":"https://doi.org/10.1038/leu.2015.265","pdf_url":"https://www.nature.com/articles/leu2015265.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/leu2015265.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"G Garcia-Manero","raw_affiliation_strings":["Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101760493","display_name":"Steven D. Gore","orcid":"https://orcid.org/0000-0002-3649-8758","observed_orcids":["https://orcid.org/0000-0002-3649-8758"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S D Gore","raw_affiliation_strings":["Yale Cancer Center, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Cancer Center, New Haven, CT, USA","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017739829","display_name":"Suman Kambhampati","orcid":"https://orcid.org/0000-0002-8527-1365","observed_orcids":["https://orcid.org/0000-0002-8527-1365"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Kambhampati","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Scott","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Tefferi","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042492175","display_name":"Christopher Ramin Cogle","orcid":"https://orcid.org/0000-0001-5422-6863","observed_orcids":["https://orcid.org/0000-0001-5422-6863"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C R Cogle","raw_affiliation_strings":["Medicine/Hematology & Oncology, University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine/Hematology & Oncology, University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006591586","display_name":"William Jeffery Edenfield","orcid":"https://orcid.org/0000-0001-8232-2318","observed_orcids":["https://orcid.org/0000-0001-8232-2318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W J Edenfield","raw_affiliation_strings":["Cancer Centers of The Carolinas, Greenville, SC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Centers of The Carolinas, Greenville, SC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003299911","display_name":"Joel Hetzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Hetzer","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022567987","display_name":"Kailash Kumar","orcid":"https://orcid.org/0000-0001-8613-5835","observed_orcids":["https://orcid.org/0000-0001-8613-5835"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Kumar","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052836154","display_name":"Eric J. Laille","orcid":"https://orcid.org/0000-0002-7823-0004","observed_orcids":["https://orcid.org/0000-0002-7823-0004"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Laille","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035705128","display_name":"Tao Shi","orcid":"https://orcid.org/0009-0002-2503-2845","observed_orcids":["https://orcid.org/0009-0002-2503-2845","https://orcid.org/0009-0008-3174-1334"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T Shi","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063041606","display_name":"Kyle J. MacBeth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K J MacBeth","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112155324","display_name":"B. S. SKIKNE","orcid":"https://orcid.org/0000-0002-2439-8485","observed_orcids":["https://orcid.org/0000-0002-2439-8485"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Skikne","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA","institution_ids":["https://openalex.org/I4387155837"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5061026876"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":9.6894,"has_fulltext":true,"cited_by_count":114,"citation_normalized_percentile":{"value":0.98314471,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"30","issue":"4","first_page":"889","last_page":"896"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cc-486","display_name":"CC-486","score":0.9860000014305115},{"id":"https://openalex.org/keywords/oral-azacitidine","display_name":"oral azacitidine","score":0.984000027179718},{"id":"https://openalex.org/keywords/lower-risk-myelodysplastic-syndromes","display_name":"lower-risk myelodysplastic syndromes","score":0.902999997138977},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8009999990463257},{"id":"https://openalex.org/keywords/epigenetic-modifiers","display_name":"epigenetic regulators","score":0.8510000109672546},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.6290000081062317},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.7229999899864197},{"id":"https://openalex.org/keywords/transfusion-independence","display_name":"transfusion independence","score":0.953000009059906},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.9072251319885254},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8338793516159058},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.8202423453330994},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6599607467651367},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48125407099723816},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44999492168426514},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1337704360485077},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0969306230545044},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07776516675949097},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/leu.2015.265","doi":"https://doi.org/10.1038/leu.2015.265","is_oa":true,"landing_page_url":"https://doi.org/10.1038/leu.2015.265","pdf_url":"https://www.nature.com/articles/leu2015265.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4832070","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4832070","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Text"},{"id":"pmid:26442612","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26442612","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1038/leu.2015.265","doi":"https://doi.org/10.1038/leu.2015.265","is_oa":true,"landing_page_url":"https://doi.org/10.1038/leu.2015.265","pdf_url":"https://www.nature.com/articles/leu2015265.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2952206036","display_name":"Targeting Epigenomics in Myeloid Neoplasms","funder_award_id":"K24CA111717","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2265091238.pdf","grobid_xml":"https://content.openalex.org/works/W2265091238.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W187238933","https://openalex.org/W215808923","https://openalex.org/W1581590112","https://openalex.org/W1583956358","https://openalex.org/W1591598277","https://openalex.org/W1615743071","https://openalex.org/W1883939012","https://openalex.org/W1893997768","https://openalex.org/W1905936368","https://openalex.org/W1967049462","https://openalex.org/W1988267450","https://openalex.org/W1988907854","https://openalex.org/W1991858306","https://openalex.org/W2000252768","https://openalex.org/W2003081290","https://openalex.org/W2009650262","https://openalex.org/W2013850239","https://openalex.org/W2014432992","https://openalex.org/W2021572674","https://openalex.org/W2024088186","https://openalex.org/W2026652967","https://openalex.org/W2034602099","https://openalex.org/W2037710811","https://openalex.org/W2063607020","https://openalex.org/W2066728239","https://openalex.org/W2089770204","https://openalex.org/W2102544902","https://openalex.org/W2104076485","https://openalex.org/W2106584820","https://openalex.org/W2106833395","https://openalex.org/W2118771330","https://openalex.org/W2123710752","https://openalex.org/W2125347906","https://openalex.org/W2125956833","https://openalex.org/W2129510594","https://openalex.org/W2136905998","https://openalex.org/W2143319558","https://openalex.org/W2148033621","https://openalex.org/W2148428508","https://openalex.org/W2158269380","https://openalex.org/W2158324181","https://openalex.org/W2181468201","https://openalex.org/W2406313600","https://openalex.org/W6681234043"],"related_works":["https://openalex.org/W2979345711","https://openalex.org/W1615743071","https://openalex.org/W2884246240","https://openalex.org/W2593191135","https://openalex.org/W2555024572","https://openalex.org/W2198196477","https://openalex.org/W2568528737","https://openalex.org/W3139163066","https://openalex.org/W2021523266","https://openalex.org/W3095504066"],"abstract_inverted_index":{"CC-486,":[0],"the":[1,56,122,130],"oral":[2,190],"formulation":[3],"of":[4,20,58,87,101,113,159,189],"azacitidine":[5],"(AZA),":[6],"is":[7,49],"an":[8],"epigenetic":[9],"modifier":[10],"and":[11,46,63,99,126,164,179],"DNA":[12,47],"methyltransferase":[13],"inhibitor":[14],"in":[15,34],"clinical":[16],"development":[17],"for":[18,25,79,121,129,197],"treatment":[19,30,115,196],"hematologic":[21,149],"malignancies.":[22],"CC-486":[23,52,76,114,182,191],"administered":[24],"7":[26,118],"days":[27,81,85],"per":[28],"28-day":[29,89],"cycle":[31],"was":[32,94,117,155,183],"evaluated":[33],"a":[35,42],"phase":[36],"1":[37],"dose-finding":[38],"study.":[39],"AZA":[40],"has":[41],"short":[43],"plasma":[44],"half-life":[45],"incorporation":[48],"S-phase-restricted;":[50],"extending":[51],"exposure":[53],"may":[54,192],"increase":[55],"number":[57,112],"AZA-affected":[59],"diseased":[60],"target":[61],"cells":[62],"maximize":[64],"therapeutic":[65],"effects.":[66],"Patients":[67],"with":[68,174,199],"lower-risk":[69,200],"myelodysplastic":[70],"syndromes":[71],"(MDS)":[72],"received":[73],"300":[74],"mg":[75],"once":[77],"daily":[78],"14":[80],"(n=28)":[82],"or":[83,136,143,148],"21":[84],"(n=27)":[86],"repeated":[88],"cycles.":[90],"Median":[91,111],"patient":[92],"age":[93],"72":[95],"years":[96],"(range":[97,119],"31-87)":[98],"75%":[100],"patients":[102,160,198],"had":[103],"International":[104],"Prognostic":[105],"Scoring":[106],"System":[107],"Intermediate-1":[108],"risk":[109],"MDS.":[110,201],"cycles":[116],"2-24)":[120],"14-day":[123,162],"dosing":[124,163,176,187],"schedule":[125],"6":[127],"(1-24)":[128],"21-day":[131,167],"schedule.":[132],"Overall":[133],"response":[134],"(complete":[135],"partial":[137],"remission,":[138],"red":[139],"blood":[140],"cell":[141],"(RBC)":[142],"platelet":[144],"transfusion":[145],"independence":[146],"(TI),":[147],"improvement)":[150],"(International":[151],"Working":[152],"Group":[153],"2006)":[154],"attained":[156],"by":[157],"36%":[158],"receiving":[161,166],"41%":[165],"dosing.":[168],"RBC":[169],"TI":[170],"rates":[171],"were":[172],"similar":[173],"both":[175],"schedules":[177,188],"(31%":[178],"38%,":[180],"respectively).":[181],"generally":[184],"well-tolerated.":[185],"Extended":[186],"provide":[193],"effective":[194],"long-term":[195]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}